Nefrodata - ACD 4.8

Streamlined application designed to help nephrology teams capture, organize, and review kidney care data with clarity and speed
Rating
Your vote:
Latest version:
4.8 See all
Developer:
Nefrodata Sistemas & Lifesys Informática LTDA
No screenshots
Used by 1 person
Request
Download
link when available

Nefrodata - ACD is a streamlined application designed to help nephrology teams capture, organize, and review kidney care data with clarity and speed. It brings labs, clinical observations, dialysis session details, and care plans together in one place, making it easier to standardize documentation, monitor trends, and support informed decisions across clinics and research settings. With an intuitive interface and configurable workflows, Nefrodata - ACD helps reduce manual effort, improve data consistency, and keep teams aligned.

Key features:

  • Centralized data capture for labs, vitals, dialysis sessions, and notes
  • Clear dashboards to track patient status and trends over time
  • Customizable forms, fields, and tags to match local protocols
  • Smart search and filtering for fast record retrieval
  • Report and export tools for audits, handovers, and research
  • Role-based access and activity logs to support team accountability
  • Notifications and reminders to stay on top of follow-ups
  • Works across teams and locations to streamline collaboration

Note: Nefrodata - ACD is a documentation and workflow support tool and does not replace professional medical judgment or provide medical diagnoses. If you’d like this description tailored to a specific platform or audience, share a few details and I’ll refine it.

Nefrodata - ACD is developed by Nefrodata Sistemas & Lifesys Informática LTDA and is used by 1 user of Software Informer. The most popular version of this product among our users is 4.8. The name of the program executable file is ACD.EXE.

You can check ACDSee Pro, Advanced IM Password Recovery, Esko ArtiosCAD Viewer and other related programs like ACD FotoSlate at the "download" section.

Comments

User

Your vote: